Apeloa Pharmaceutical (SHE:000739) signed a strategic cooperation framework agreement with Jitai Technology Beijing to collaborate on contract development and manufacturing organization (CDMO) services and related projects.
The five-year partnership positions Apeloa as the preferred CDMO provider for Jitai and its affiliates, while exploring new project companies and joint investments, according to a Tuesday filing with the Shenzhen bourse.